Anticancer activities of parthenolide in primary effusion lymphoma preclinical models.
Saved in:
| Title: | Anticancer activities of parthenolide in primary effusion lymphoma preclinical models. |
|---|---|
| Authors: | Karam L; Faculty of Sciences, GSBT Laboratory, R. Hariri Campus, Lebanese University, Hadath, Lebanon.; Department of Natural Sciences, School of Arts & Sciences, Lebanese American University, Beirut, Lebanon., Abou Staiteieh S; Faculty of Sciences, GSBT Laboratory, R. Hariri Campus, Lebanese University, Hadath, Lebanon., Chaaban R; Faculty of Sciences, GSBT Laboratory, R. Hariri Campus, Lebanese University, Hadath, Lebanon., Hayar B; Department of Biochemistry and Molecular Genetics, American University of Beirut, Beirut, Lebanon., Ismail B; Faculty of Sciences, GSBT Laboratory, R. Hariri Campus, Lebanese University, Hadath, Lebanon., Neipel F; Virologisches Institut, Universitätsklinikum Erlangen, Erlangen, Germany., Darwiche N; Department of Biochemistry and Molecular Genetics, American University of Beirut, Beirut, Lebanon., Abou Merhi R; Faculty of Sciences, GSBT Laboratory, R. Hariri Campus, Lebanese University, Hadath, Lebanon. |
| Source: | Molecular carcinogenesis [Mol Carcinog] 2021 Aug; Vol. 60 (8), pp. 567-581. Date of Electronic Publication: 2021 Jun 08. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8811105 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-2744 (Electronic) Linking ISSN: 08991987 NLM ISO Abbreviation: Mol Carcinog Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
